Klotho therapeutics stock
WebNov 3, 2024 · Xconomy San Diego —. Klotho Therapeutics, a virtual biotech developing a kidney disease treatment based on its proprietary engineered version of the human klotho enzyme, said Thursday it has raised $10 million in Series A financing from San Diego’s Thynk Capital. Thynk Capital founder and principal Jim Plante also is Klotho’s founder and CEO. WebKlotho Therapeutics, Inc. 87 likes. Klotho Therapeutics, Inc., (KTI) is a pre-clinical biotechnology company developing modified recombi
Klotho therapeutics stock
Did you know?
WebNov 3, 2024 · Klotho Therapeutics has raised a total of $10M in funding over 1 round. This was a Series A round raised on Nov 3, 2024. Klotho Therapeutics is funded by Thynk Capital, LLC.. Klotho Therapeutics has a post-money valuation in the range of $10M to $50M as of Nov 3, 2024, according to PrivCo. WebThe antiaging, life-extending, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidative, and pro-myelinating effects. In addition, Klotho is also a tumor suppressor and has beneficial roles in multiple organs. Klotho is downregulated as part of the aging process.
WebThynk Capital was founded by entrepreneur, inventor and investor, Jim Plante. Jim has been Investing for almost 20 years primarily in early stage technology and life science companies with 100X return potential with a particular interest in extending Health Span and addressing the major diseases of Aging including Alzheimers, Kidney Disease ... WebKLOTHO THERAPEUTICS™ And LIVE WELL LONGER™ Are Trademarks Of KLOTHO THERAPEUTICS, INC. Facebook ...
WebNov 3, 2024 · Klotho Therapeutics is funded by Thynk Capital, LLC.. Klotho Therapeutics has a post-money valuation in the range of $10M to $50M as of Nov 3, 2024 , according to … WebNov 8, 2024 · Klotho Therapeutics Raises $10 Million for Kidney Disease Treatment. Klotho, one of SDVG’s 2024 Cool Companies, announced a first closing of their Series A for $10 million, led by Thynk Capital. Klotho is also the name of the company’s recombinant protein therapeutic in development to treat kidney disease.
WebJun 11, 2024 · Klotho Therapeutics, also known as KTI, is actually one of the closest companies to getting started. They're expected to enter human trials with their patent-pending protein in as little as 2 years. This is good news for those who suffer from chronic kidney problems, as they may begin to see relief in the coming years.
WebApr 29, 2024 · the Egr1-binding sites. We further enhanced Klotho's activation using p65-Rta tran-scriptional activation domains in addition to VP64. These upregulation approaches could be useful for studying Klotho's protective effects and designing Klotho boost-ing therapeutics for future in vivo experiments. connect wireless display to macbookWebNov 2, 2024 · SAN DIEGO, Nov. 2, 2024 /PRNewswire/ -- Klotho Therapeutics, Inc. (KTI), a biotechnology company focused on commercializing its patent pending version of the … edit any page codeWebView Klotho Therapeutics (www.klotho.com) location in Delaware, United States , revenue, industry and description. Find related and similar companies as well as employees by title … edit any page javascript bookmarkletWebKlotho Therapeutics, Inc. 548 followers on LinkedIn. Helping people live well longer Klotho Therapeutics, Inc., (KTI) is a privately held biotechnology company developing modified recombinant ... connect wireless controller to windows 10WebApr 9, 2024 · An amount of 200 µM palmitic acid conjugated to fatty-acid-free bovine serum albumin solution was prepared, as described below. One 100 mM palmitic acids stock solution was prepared in DMSO by heating at 70 °C in a shaking water bath. In an adjacent water bath at 55 °C, a 10% (w/v) fatty-acid-free bovine serum albumin solution was … edit any lot cheat sims 4WebKlotho Therapeutics, Inc., (KTI) is a pre-clinical biotechnology company developing modified recombi Page · Biotechnology Company [email protected] klotho.com/contact Not yet rated (1 Review) Photos See all photos Privacy · Terms · Advertising · Ad Choices · Cookies · More · Meta © 2024 Klotho Therapeutics, Inc updated their cover photo. connect wireless display win 11WebKLOTHO Therapeutics (KTI ™) is a biotechnology company developing a patent-pending Klotho protein that has great potential to redefine society’s experience with aging. KTI … edit anything bookmark